Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...

SAN ANTONIO, July 09, 2025--bioAffinity Technologies' CyPath® Lung detects Stage 1A lung cancer when imaging was inconclusive ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and ...

Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...

With EAGLE, lung cancer biopsy analysis is expedited, accurately predicting EGFR mutations and streamlining the diagnostic process for better patient outcomes.

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

While cancer-associated fibroblasts (CAFs) significantly influence tumor progression, their temporal dynamics remain poorly understood. We investigated time-dependent interactions between non-small ...

During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...

A recent study reveals a direct link between air pollution and lung cancer, identifying increased DNA mutations in ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.

AstraZeneca receives CDSCO approval for Durvalumab, a new treatment for muscle-invasive bladder cancer in India. This marks a ...